Rademikibart IV for Acute Asthma and COPD Exacerbation
Rademikibart IV for Acute Asthma and COPD Exacerbation
Recruiting · NCT07705737 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rademikibart IV for Acute Asthma and COPD Exacerbation | Chronic Disease, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, chronic obstructive pulmonary disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-08-27 | NCT07705737 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Connect Biopharm LLC | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbus Clinical Services, LLC | Miami | United States | 1 |
| Pharmax Research of South Florida, Inc. | Miami | United States | 1 |